BIOMAT Database Logo BIOMAT Database Logo

[The advantages of using ganglionic blockaders in oncologic patients]. 1971

G D Monchenko, and V I Chirkov, and E G Grigor'ev

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D005260 Female Females
D005730 Ganglionic Blockers Agents having as their major action the interruption of neural transmission at nicotinic receptors on postganglionic autonomic neurons. Because their actions are so broad, including blocking of sympathetic and parasympathetic systems, their therapeutic use has been largely supplanted by more specific drugs. They may still be used in the control of blood pressure in patients with acute dissecting aortic aneurysm and for the induction of hypotension in surgery. Ganglionic Blocking Agents,Ganglioplegic Agents,Blocking Agents, Ganglionic,Ganglionic Blockaders,Agents, Ganglionic Blocking,Agents, Ganglioplegic,Blockaders, Ganglionic,Blockers, Ganglionic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

G D Monchenko, and V I Chirkov, and E G Grigor'ev
[Ganglionic blockaders in the therapy of pulmonary hemorrhage].
November 1969, Vrachebnoe delo,
G D Monchenko, and V I Chirkov, and E G Grigor'ev
[Ganglionic blockaders in the treatment of gastrointestinal hemorrhage].
November 1972, Polski przeglad chirurgiczny,
G D Monchenko, and V I Chirkov, and E G Grigor'ev
[Increased sensitivity of cancer patients to ganglionic blockaders during anesthesia].
January 1985, Voprosy onkologii,
G D Monchenko, and V I Chirkov, and E G Grigor'ev
[Mode of action of amidinothiocholine ganglionic blockaders].
January 1972, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
G D Monchenko, and V I Chirkov, and E G Grigor'ev
[Use of ganglionic blockaders in the treatment of patients with closed thoracic injuries].
November 1989, Vestnik khirurgii imeni I. I. Grekova,
G D Monchenko, and V I Chirkov, and E G Grigor'ev
[Ganglionic blockaders in the treatment of cardio-pulmonary insufficiency in patients with pulmonary tuberculosis].
May 1972, Vrachebnoe delo,
G D Monchenko, and V I Chirkov, and E G Grigor'ev
[Ganglionic blockaders in the preoperative care and treatment of nodular goiter].
June 1975, Klinicheskaia khirurgiia,
G D Monchenko, and V I Chirkov, and E G Grigor'ev
[Effect of ganglionic blockaders on the urinary ascorbic acid excretion in patients with peptic ulcer].
March 1972, Vrachebnoe delo,
G D Monchenko, and V I Chirkov, and E G Grigor'ev
[Use of ganglionic blockaders in the differential diagnosis of the pseudoperitoneal syndrome].
January 1982, Sovetskaia meditsina,
G D Monchenko, and V I Chirkov, and E G Grigor'ev
[Role of different vascular regions in the hypotensive effect of ganglionic blockaders].
January 1971, Farmakologiia i toksikologiia,
Copied contents to your clipboard!